Additional file 1 of Institutional outbreak involving multiple clades of IMP-producing Enterobacter cloacae complex sequence type 78 at a cancer center in Tokyo, Japan
Sohei Harada(University of Tokyo Hospital), Brian Hayama(Japanese Foundation For Cancer Research), Koh Okamoto(Rush University Medical Center), Keito Ida(Japanese Foundation For Cancer Research), Kazumi Takehana(Japanese Foundation For Cancer Research), Yoshikazu Ishii(Toho University), Kyoji Moriya(University of Tokyo Hospital), Daisuke Ohkushi(Japanese Foundation For Cancer Research), Daigo Shoji(Japanese Foundation For Cancer Research), Kotaro Aoki(Toho University), Tomomi Akatsuchi(Japanese Foundation For Cancer Research), Yohei Doi(Fujita Health University)
Cited by 0
Related Papers
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
|The Lancet Infectious Diseases|2021|338
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
|The Lancet Infectious Diseases|2020|328
Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by<i>Enterobacter</i>,<i>Citrobacter</i>or<i>Serratia</i>species: a systematic review with meta-analysis
|Journal of Antimicrobial Chemotherapy|2015|86
Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition
|Clinical Microbiology and Infection|2016|83